We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.6B
AUM Growth
-$1.02B
Cap. Flow
-$902M
Cap. Flow %
-6.19%
Top 10 Hldgs %
33.67%
Holding
1,168
New
194
Increased
342
Reduced
403
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$56M
2
CSCO icon
Cisco
CSCO
+$49.4M
3
META icon
Meta Platforms (Facebook)
META
+$45.4M
4
CVE icon
Cenovus Energy
CVE
+$40.5M
5
BNS icon
Scotiabank
BNS
+$39.8M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Energy 13.55%
3 Industrials 13.52%
4 Technology 10.79%
5 Materials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
176
Air Products & Chemicals
APD
$67.7B
$9.66M 0.07%
43,540
+18,375
+73% +$4.13M
CMI icon
177
Cummins
CMI
$87.8B
$9.66M 0.07%
59,373
-20,027
-25% -$3.2M
CNP icon
178
CenterPoint Energy
CNP
$26.7B
$9.66M 0.07%
319,981
-202,050
-39% -$5.82M
IEX icon
179
IDEX
IEX
$17.7B
$9.63M 0.07%
+58,775
New +$9.75M
C icon
180
Citigroup
C
$231B
$9.53M 0.07%
137,949
-135,057
-49% -$9.19M
PDLI
181
DELISTED
PDL BioPharma, Inc.
PDLI
$9.48M 0.07%
4,387,038
-100,546
-2% -$269K
AMP icon
182
Ameriprise Financial
AMP
$49.9B
$9.18M 0.06%
62,375
-6,200
-9% -$869K
AMAG
183
DELISTED
AMAG Pharmaceuticals
AMAG
$9.17M 0.06%
794,065
+3,641
+0.5% +$38.3K
TERP
184
DELISTED
TerraForm Power, Inc
TERP
$9.17M 0.06%
503,033
+189,102
+60% +$3.06M
WUBA
185
DELISTED
58.com Inc
WUBA
$8.88M 0.06%
180,177
+109,900
+156% +$6.08M
VVX icon
186
V2X
VVX
$2.55B
$8.85M 0.06%
217,747
-4,006
-2% -$165K
WD icon
187
Walker & Dunlop
WD
$1.45B
$8.8M 0.06%
157,390
-18,650
-11% -$1.05M
GME icon
188
GameStop
GME
$8.32B
$8.79M 0.06%
6,368,620
+3,646,676
+134% +$3.94M
INFY icon
189
Infosys
INFY
$49.7B
$8.65M 0.06%
760,511
+587,121
+339% +$6.61M
UN
190
DELISTED
Unilever NV New York Registry Shares
UN
$8.64M 0.06%
143,960
-1,340
-0.9% -$80.5K
ROST icon
191
Ross Stores
ROST
$79.6B
$8.59M 0.06%
78,150
+22,925
+42% +$2.42M
KEYS icon
192
Keysight
KEYS
$60.6B
$8.53M 0.06%
87,656
-47,369
-35% -$4.39M
CRH icon
193
CRH
CRH
$65.2B
$8.43M 0.06%
245,199
-170,476
-41% -$5.65M
WWD icon
194
Woodward
WWD
$21.4B
$8.39M 0.06%
77,800
+26,425
+51% +$2.9M
GT icon
195
Goodyear
GT
$1.74B
$8.14M 0.06%
565,307
-15,350
-3% -$204K
GTE icon
196
Gran Tierra Energy
GTE
$331M
$8.12M 0.06%
655,728
-122,741
-16% -$1.79M
NTAP icon
197
NetApp
NTAP
$39.6B
$8.11M 0.06%
154,450
+33,150
+27% +$1.78M
FLR icon
198
Fluor
FLR
$6.96B
$8.08M 0.06%
422,419
+191,244
+83% +$4.57M
HUM icon
199
Humana
HUM
$46.7B
$8.06M 0.06%
31,534
+2,038
+7% +$571K
LADR
200
Ladder Capital
LADR
$1.25B
$7.98M 0.05%
461,862
-96,908
-17% -$1.64M

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2019 Portfolio in Review

As of Q3 2019, Connor, Clark & Lunn Investment Management (CC&L) held 1,168 positions worth $14.6B, down 6.5% from $15.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $902M in Q3 2019, closing 225 positions and reducing 403 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Fidelity National Information Services worth $29.9M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2019 buy was Fidelity National Information Services: 225,271 shares worth $29.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Pfizer in Q3 2019, an estimated $56M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2019 reduction was Toronto Dominion Bank, cutting an estimated $105M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Bristol-Myers Squibb in Q3 2019, selling an estimated $37.2M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.6B portfolio in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 194 new positions and closed 225 in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 6.5% quarter-over-quarter to $14.6B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.